Language selection

Search

Patent 2736357 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2736357
(54) English Title: NANO GLUCOSE MONITORING DEVICE
(54) French Title: DISPOSITIF NANOTECHNOLOGIQUE DE MESURE DE LA GLYCEMIE
Status: Dead
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61B 5/1455 (2006.01)
  • G04B 47/06 (2006.01)
(72) Inventors :
  • BASHKAIL, ABDULRAHMAN MOHAMMAD S. (Canada)
(73) Owners :
  • BASHKAIL, ABDULRAHMAN MOHAMMAD S. (Canada)
(71) Applicants :
  • BASHKAIL, ABDULRAHMAN MOHAMMAD S. (Canada)
(74) Agent: NA
(74) Associate agent: NA
(45) Issued:
(22) Filed Date: 2011-04-07
(41) Open to Public Inspection: 2012-10-07
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract





I have recognized the importance of self-monitoring of blood glucose
concentration for prevention
of complications in patients with diabetes. I have created an idea of a nano
product that will
improve the process of monitoring blood glucose levels in patients with
diabetes without the need to
continuously prick their fingers and taking a sample of blood. My product is
designed as a
wristwatch with a digital screen and works with nanotechnology. A
nanospectrophotometric
analysis releases light through unbreakable glass which is placed in the
backside of the attached
watch to the wrist of human, which identifies the characteristics of cells in
the blood. A nanoscale in
the device uses this information which is provided by nanospectrophotometric
analysis to calculate
and measure the amount and concentration of glucose in the blood and displays
the results through a
digital screen. So, the device continuously works night and day and
automatically releases beeps to
alert diabetics in case of low or high glucose in the blood.


Claims

Note: Claims are shown in the official language in which they were submitted.





Claims:

The embodiments of the invention in which an exclusive property or privilege
is claimed are
defined as follows:


1. The Nano blood glucose monitoring device is created for diabetics to
monitor their glucose
levels without pricking their fingers and taking a sample of blood. A
nanospectrophotometric analysis releases light through unbreakable glass which
is placed in
the backside of the attached watch to the wrist of human, which identifies the
characteristics
of cells in the blood. A nanoscale uses this information to calculate and
measure the amount
and concentration of glucose in the blood. Finally, a digital screen displays
the results and
issues beeps in order to alert diabetics in case of low or high glucose in the
blood.


2. A device as defined in claim 1, in which the device is designed as a
wristwatch.

3. A device as defined in claim 1 or claim 2, in which the device consists of
nanospectrophotometric analysis to emit light through unbreakable glass which
is placed in
the backside of the watch to identify the characteristics of cells in the
blood.

4. A device as defined in claim 1 or claim 2, in which the device consists of
a nanoscale that
uses the information which is collected by nanospectrophotometric analysis to
calculate and
measure the amount and concentration of glucose in the blood.

5. A device as defined in claim 1 or claim 2, in which the device consists of
a digital screen to
display the results and issues beeps.



3

Description

Note: Descriptions are shown in the official language in which they were submitted.



CA 02736357 2011-04-07
Specification:

This invention relates to self-monitoring of blood glucose levels in patients
with diabetes.

It is common that regular blood glucose monitoring devices require samples of
blood to calculate
and measure the amount of glucose level in the blood. Diabetics continuously
prick their fingers to
check their glucose levels at least once a day. This process is painful,
especially for children and
seniors, and because of this, diabetics must pay for strips and other
accessories as well. In addition,
Diabetics could not monitor their sugar and often are exposed to risks because
of the low or high
level of sugar while they are sleeping, playing outdoors, at school or at
work.

I have found that my product would overcome the regular blood glucose
monitoring devices'
disadvantages. My product does not need to have a sample of blood to measure
the amount of
glucose level in the blood so there are no strips and physical pain. Moreover,
it would monitor the
level of glucose of diabetics while they are sleeping, busy, playing outdoors,
at school or at work,
and alert them to react to oncoming highs or lows of sugar by issuing beeps.
It is also waterproof so
it can be worn while swimming, bathing, or showering without worries.

In drawings which illustrate embodiments of the invention, figure 2 shows the
shape of the Nano
Glucose Monitoring Device. Figure 1 shows the components and processes of Nano
Glucose
Monitoring Device as following: Nanospectrophotometric analysis 1 releases
light 2 through
unbreakable glass 3 which is placed in the backside of the attached watch to
the wrist of human 4,
which identifies the characteristics of cells in the blood. A nanoscale 5 in
the device uses this
information which is provided by nanospectrophotometric analysis to calculate
and measure the
amount and concentration of glucose in the blood. Digital screen 6 which
displays the results and
issues beeps 7 in order to alert diabetics in the case of low or high glucose
in the blood.

2

Representative Drawing

Sorry, the representative drawing for patent document number 2736357 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date Unavailable
(22) Filed 2011-04-07
(41) Open to Public Inspection 2012-10-07
Dead Application 2014-04-08

Abandonment History

Abandonment Date Reason Reinstatement Date
2013-04-08 FAILURE TO PAY APPLICATION MAINTENANCE FEE

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $200.00 2011-04-07
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BASHKAIL, ABDULRAHMAN MOHAMMAD S.
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 2011-04-07 1 22
Description 2011-04-07 1 41
Claims 2011-04-07 1 30
Drawings 2011-04-07 1 11
Cover Page 2012-10-01 1 35
Correspondence 2011-04-21 1 12
Assignment 2011-04-07 2 72